Background. The 2023 ESC guidelines on cardiomyopathies introduce significant updates in diagnostic criteria, terminology, and treatment protocols. These guidelines aim to provide comprehensive approaches for diagnosis and management. Materials and methods. A review of the 2023 ESC guidelines and relevant literature was conducted to outline the changes in diagnostic approaches and treatment standards. Results. The ESC 2023 guidelines introduced revised diagnostic criteria for cardiomyopathies, added new terms such as non-dilated left ventricular cardiomyopathy (NDLVC), and updated treatment specifications, emphasizing personalized approaches and genetic considerations. Conclusion. The ESC 2023 guidelines provide essential updates that refine the diagnosis and treatment of cardiomyopathies, promoting improved clinical practices.
| Mualliflar | Абдуллаев , Т, Цой , И, Abdullaev , Timur, Tsoi , Igor, Abdullaev , Timur, Tsoi , Igor |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-03-30 |
| Jild | 1 |
| Son | 1 |
| Betlar | 29-35 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00004 |
DOI: 10.70626/cardiouz-2024-1-00004 · Maqolaning asl sahifasi
рекомендации ESC, кардиомиопатия, клиническая практика, лечение, диагностика, ESC guidelines, cardiomyopathy, diagnosis, treatment, clinical practice, ESC Guidelines, Kardiomiyopatiya, Tashxis, Davolash, Klinik amaliyot
Background. This study explores the impact of anxiety and depressive disorders on the rehabilitation outcomes and long-term prognosis of patients with acute myocardial infarction (AMI) and unstable angina. The aim is to…
Background. Contrast-induced nephropathy (CIN) is a common complication among patients with ischemic heart disease (IHD) undergoing percutaneous coronary intervention (PCI). Understanding the pathogenesis, risk factors…
Background. Atherosclerosis is a leading cause of cardiovascular mortality worldwide, significantly impacting public health. microRNA, as key regulators of gene expression, play a crucial role in the pathogenesis of…
Background. To assess the frequency and characteristics of cardiac arrhythmias in relation to cardiac remodeling and blood prolactin levels in patients with peripartum cardiomyopathy (PPCM). Materials and methods. The…
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…
Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased…
Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and…
The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic…
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations…
Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors…